Patterson Robert M 4

Accession 0001127602-21-024543

CIK 0001122976other

View on SEC.gov Company Profile

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 4:23 PM ET

Size

38.8 KB

Accession

0001127602-21-024543

Insider Transaction Report

Form 4

Period: 2021-05-07

AVIENT CORPAVNT

Patterson Robert M

SVP & Chief Financial Officer

Transactions

Disposition to Issuer
Common Stock
2021-08-27$52.49/sh−56,645$2,973,296→ 395,297 total
Exercise/Conversion
Common Stock
2021-08-27$41.89/sh+63,034$2,640,494→ 512,057 total
Exercise/Conversion
Common Stock
2021-08-27$31.48/sh+57,517$1,810,635→ 536,344 total
Gift
Common Stock
2021-05-07−5,000→ 385,242 total
Disposition to Issuer
Common Stock
2021-08-27$52.49/sh−74,518$3,911,450→ 425,979 total
Disposition to Issuer
Common Stock
2021-08-27$52.49/sh−95,156$4,994,738→ 449,023 total
Disposition to Issuer
Common Stock
2021-08-27$52.49/sh−79,579$4,177,102→ 478,827 total
Disposition to Issuer
Common Stock
2021-08-27$52.49/sh−44,706$2,346,618→ 491,638 total
Exercise/Conversion
Stock Appreciation Rights
2021-08-27−66,700→ 0 total
Exercise: $38.27Exp: 2025-02-04→ Common Stock (66,700 underlying)
Exercise/Conversion
Stock Appreciation Rights
2021-08-27−118,200→ 0 total
Exercise: $34.10Exp: 2027-02-15→ Common Stock (118,200 underlying)
Exercise/Conversion
Stock Appreciation Rights
2021-08-27−102,300→ 51,150 total
Exercise: $31.54Exp: 2029-02-11→ Common Stock (102,300 underlying)
Discretionary Transaction
Common Stock
2021-08-27$52.49/sh−121,277.52$6,365,857→ 0 total(indirect: Supplemental Plan)
Exercise/Conversion
Common Stock
2021-08-27$38.27/sh+66,700$2,552,609→ 451,942 total
Exercise/Conversion
Common Stock
2021-08-27$24.98/sh+105,200$2,627,896→ 500,497 total
Exercise/Conversion
Common Stock
2021-08-27$34.10/sh+118,200$4,030,620→ 544,179 total
Disposition to Issuer
Common Stock
2021-08-27$52.49/sh−55,951$2,936,868→ 456,106 total
Exercise/Conversion
Common Stock
2021-08-27$31.54/sh+102,300$3,226,542→ 558,406 total
Exercise/Conversion
Stock Appreciation Rights
2021-08-27−57,517→ 115,033 total
Exercise: $31.48Exp: 2030-02-10→ Common Stock (57,517 underlying)
Exercise/Conversion
Stock Appreciation Rights
2021-08-27−105,200→ 0 total
Exercise: $24.98Exp: 2026-02-10→ Common Stock (105,200 underlying)
Exercise/Conversion
Stock Appreciation Rights
2021-08-27−63,034→ 31,516 total
Exercise: $41.89Exp: 2028-02-14→ Common Stock (63,034 underlying)

Footnotes (9)

[F1]Reflects an exempt intra-plan transfer (rule 16b-3(f)) by the reporting person of value out of the Avient stock fund and into one or more other investments under the Issuer's Supplemental Retiremet Benefit Plan pursuant to a pre-arranged trading plan.
[F2]Includes shares acquired pursuant to dividend reinvestment.
[F3]The listed SAR transactions were completed pursuant to a pre-arranged trading plan.
[F4]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.
[F5]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.
[F6]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $34.10 per share and no more than one-third of the grant can vest per year during the first three years.
[F7]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.
[F8]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.
[F9]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

AVIENT CORP

CIK 0001122976

→

Entity typeother

Related Parties

filerCIK 0001433828

Filing Metadata

Form type: 4
Filed: Aug 29, 8:00 PM ET
Accepted: Aug 30, 4:23 PM ET
Size: 38.8 KB

View on SEC.gov